Active-ingredient Dossier
Ibuprofen
Active-ingredient Dossier for Ibuprofen (nonsteroidal anti-inflammatory drug). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: PEDEA
- Brand: CALDOLOR
- Brand: AMCAL
- Brand: BRUFEN®
- Brand: IBUDEINE
- Brand: IBUPROFEN/CODEINE-TIH
- Therapeutic area: Pain Management
- Therapeutic area: Respiratory
- Therapeutic area: Rare Disease
What is
Ibuprofen Ibuprofen is a nonsteroidal anti-inflammatory drug.
Australian brands containing
Ibuprofen — APO-IBUPROFEN — CALDOLOR — AMCAL — BRUFEN® — IBUPROFEN/CODEINE-WGR — MAXICLEAR — MAXIGESIC — MERSYNOFEN — NUROFEN — NUROMOL DUAL ACTION PAIN — PEDEA — PHARMACY OWN
Therapeutic areas
Ibuprofen is registered across multiple therapeutic areas, with the highest concentration in Pain & Anaesthesia (38 brands) and Pain Management (17 brands). It is also registered in Respiratory (2 brands), Immunology (1 brand), and Rare Disease (1 brand).
Sponsor landscape
Ibuprofen is marketed by multiple sponsors including Neo Health (OTC), Nova Pharmaceuticals, Ipca Pharma, AFT Pharmaceuticals, Haleon, and BSPS Aust.
PBS and regulatory activity
One brand containing ibuprofen has PBS-listed items, with the latest PBS schedule date of 1 May 2026. No brands have recent PBAC outcomes on record. One brand has an AusPAR on record, dated 28 February 2012.